Response to the letter by Acar
| Medienart: |
Artikel |
|---|
| Erscheinungsjahr: |
2012 |
|---|---|
| Erschienen: |
2012 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:21 |
|---|---|
| Enthalten in: |
Pharmacoepidemiology and drug safety - 21(2012), 11 vom: Nov., Seite 1245-1247 |
| Beteiligte Personen: |
Fournier, Agnès [VerfasserIn] |
|---|
| Umfang: |
2 |
|---|
| Förderinstitution / Projekttitel: |
|
|---|
| PPN (Katalog-ID): |
OLC1906030324 |
|---|
| LEADER | 01000caa a22002652 4500 | ||
|---|---|---|---|
| 001 | OLC1906030324 | ||
| 003 | DE-627 | ||
| 005 | 20230713131955.0 | ||
| 007 | tu | ||
| 008 | 121030s2012 xx ||||| 00| ||und c | ||
| 028 | 5 | 2 | |a sw121029_1 |
| 035 | |a (DE-627)OLC1906030324 | ||
| 035 | |a (DE-599)GBVOLC1906030324 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 082 | 0 | 4 | |a 610 |
| 084 | |a PHARM |2 fid | ||
| 100 | 1 | |a Fournier, Agnès |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Response to the letter by Acar |
| 264 | 1 | |c 2012 | |
| 300 | |a 2 | ||
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ohne Hilfsmittel zu benutzen |b n |2 rdamedia | ||
| 338 | |a Band |b nc |2 rdacarrier | ||
| 700 | 1 | |a Zureik, Mahmoud |4 oth | |
| 773 | 0 | 8 | |i Enthalten in |t Pharmacoepidemiology and drug safety |d Chichester : Wiley-Blackwell, 1992 |g 21(2012), 11 vom: Nov., Seite 1245-1247 |w (DE-627)170743403 |w (DE-600)1099748-9 |w (DE-576)032731450 |x 1053-8569 |7 nnns |
| 773 | 1 | 8 | |g volume:21 |g year:2012 |g number:11 |g month:11 |g pages:1245-1247 |g extent:2 |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a SYSFLAG_A | ||
| 912 | |a GBV_OLC | ||
| 912 | |a FID-PHARM | ||
| 912 | |a SSG-OLC-PHA | ||
| 912 | |a SSG-OLC-DE-84 | ||
| 912 | |a SSG-OPC-PHA | ||
| 912 | |a GBV_ILN_20 | ||
| 912 | |a GBV_ILN_4012 | ||
| 951 | |a AR | ||
| 952 | |d 21 |j 2012 |e 11 |c 11 |h 1245-1247 |g 2 | ||